Fresenius Medical Care AG & Co. KGaA (ETR: FME)‘s stock had its “hold” rating restated by equities researchers at DZ Bank AG in a report issued on Tuesday. They currently have a $72.73 (€56) target price on the stock.

Fresenius Medical Care AG & Co. KGaA traded down 0.89% on Tuesday, hitting €57.84. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €48.34 and a 1-year high of €60.24.

Other equities research analysts have also recently issued reports about the stock. Analysts at Bryan Garnier & Cie reiterated a “buy” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note to investors on Friday. They now have a $84.21 price target on the stock. Separately, analysts at AlphaValue downgraded shares of Fresenius Medical Care AG & Co. KGaA to a “reduce” rating in a research note to investors on Thursday, October 18th. They now have a $78.16 price target on the stock. Finally, analysts at JPMorgan Chase reiterated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note to investors on Friday, October 12th. They now have a $65.71 price target on the stock.

Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.